Escalation of antimicrobial resistance among MRSA part 2: focus on infections and treatment

How Should Focus Be Shifted From Individual Preference to Collective Wisdom for Patients at the End of Life With Antimicrobial-Resistant Infections?

“…1 Escalating rates of antimicrobial resistance have called attention to the need for antimicrobial stewardship programs and infection control measures. 2,3,4 Although antimicrobial misuse is a problem across the lifespan, overtreatment with antibacterials is common at the end of life. 5 The proportion of end-of-life or comfort-care patients receiving an antimicrobial has been estimated to be as high as 77%, 6,7,8 yet only 15% meet criteria for antimicrobial treatment.…”